Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Exp Hematol. 2011 Dec 8;40(3):187–196. doi: 10.1016/j.exphem.2011.11.009

Figure 5. Hematopoietic composition of T09214 at various time points post-transplant, compared to a non-transplanted control animal.

Figure 5

At 1 month post-transplant, T09214 has lower percentages of CD3, CD13, and CD20 cells compared to a non-transplanted control animal. By 3 and 9 months post-transplant, T09214 has regained relatively normal hematopoietic reconstitution.